483
BioRamo, LLCFDA 483 - BioRamo, LLC - January 30, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of BioRamo, LLC, a drug manufacturer in Ft Lauderdale, FL, revealed significant deficiencies in its quality control unit and material handling systems. The firm failed to adequately document investigations, ensure proper product release, and maintain effective inventory control, leading to potential contamination and mix-ups. These issues indicate a lack of adherence to good manufacturing practices.
Open in Dashboard
ID · a9960e98-5176-4059-a697-0017ded171da